Notably, we have substantial evidence that IGF2BP1 promotes the expression of ZEB1, another potent ‘EMT-driving’ transcriptional regulator, in anaplastic thyroid carcinoma-derived tumor cells (Mensch et al., in preparation). This evidence concerns the gene IGF2BP1 and thyroid gland undifferentiated (anaplastic) carcinoma.